Differentiated thyroid cancer and breast cancer account for a significant portion of endocrine-
related malignancies and predominately affect women. As hormonally responsive tissues …

Simple Summary Breast and thyroid cancer are commonly diagnosed in women. Physicians
have recognized and evaluated the phenomenon of two cancers occurring synchronously or …

Vitamin D (VitD) and its receptor (VDR) have been intensively investigated in many cancers.
As knowledge for head and neck cancer (HNC) is limited, we investigated the (pre) clinical …

Simple Summary Considering the immense development of today's therapeutic approaches
in oncology towards customized therapy, this study aimed to assess the prognostic value of …

Background The active thyroid hormone triiodothyronine (T3) has been found to have an
estrogen-like effect on breast cancer cells. Thyroid hormone receptor alpha-2 (THRα-2) acts …

Estrogen receptor alpha (ER/ESR1) mutations occur in 30% to 40% of endocrine resistant
ER-positive (ER+) breast cancer. Forkhead box A1 (FOXA1) is a key pioneer factor …

Hypothyroidism in patients with solid non-thyroid cancer is a tantalizing entity, integrating an
intriguing thyroid hormones (THs)–cancer association with the complexity of hypothyroidism …

Simple Summary There is evidence of a link between breast cancer and thyroid disease.
Patients with thyroid dysfunction have an increased incidence of breast cancer compared to …

Thyroid hormones (THs) control a wide range of physiological functions essential for
metabolism, growth, and differentiation. On a molecular level, TH action is exerted by …

Background Multifocal (MF) and multicentric (MC) breast cancers are referred to as
synchronous, multiple ipsilateral breast cancers; however, the definitions vary among the …